Board Meeting-Outcome of Board Meeting
Dear Sir(s), This is with reference to our letter ref. no. FHL/SEC/STEX/RR/2018-19, dated May 10, 2018, regarding submission of Outcome of Board Meeting held on May 10, 2018. we would like to submit that there were inadvertent typographical errors in 'Press Release' attached with the Outcome of Board Meeting. The details of which are as follows:... Fortis board recommends Hero-Burman duo for stake sale
Proposal to be placed for shareholders' approval Board Meeting-Outcome of Board Meeting
This is to inform you that the Board of Directors at its meeting held today, deliberated on all the binding offers made by IHH Healthcare Berhad, Manipal /TPG consortium, Radiant Life Care Private Limited and Hero Enterprise Investment Office and Burman Family Office and received inputs from the independent Expert Advisory Committee (EAC), reputed financial advisors viz. Standard Chartered Bank and Arpwood Capital and legal advisors- Cyril Amarchand Mangaldas appointed by the Board.... Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for York Asian Strategic Metric Master, L.P. Regulation 30 Update - IHH'S Clarification To Enhanced Revised Proposal
Dear Sir(s), This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated May 1, 2018 whereby, it was informed that the Board of Directors of Fortis Healthcare Limited ('the Company') has received Enhanced Revised Proposal from IHH Healthcare Berhad ('IHH')with a proposal to invest in the Company. It is hereby informed that the Company today i.e. May 9, 2018, has received a clarification (attached herewith) to the said offer.... Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Joint Representation Of The Directors
This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 28, 2018 titled 'Submission of Notice of Extra Ordinary General Meeting (EGM)', it is hereby informed that the Company today i.e. May 8, 2018 has received a Joint representation (attached herewith) from Dr Brian W. Tempest, Mr. Harpal Singh, Ms. Sabina Vaisoha and Lt Gen. Tejinder S. Shergill.... Manipal CEO: Latest bid for Fortis 'more risky'
Privately held Manipal Hospitals had to take a more risky approach in its latest bid for Fortis Healthcare's hospital business to see off rival suit Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UBS Principal Capital Asia Ltd Manipal revises offer for Fortis by proposing Rs 2,100-cr infusion
Suggests merger of MHEPL into FHL and increases valuation to Rs 8,358 cr Regulation 30 Update - TPG-Manipal'S New Offer
This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 25, 2018 whereby, it was informed that the Board of Directors of Fortis Healthcare Limited ('the Company') has received Revised Offer from Manipal and TPG with a proposal to invest in the Company. It is hereby informed that the Company today i.e. May 6, 2018, has received a New Offer, as attached herewith....